Amylin Pharmaceuticals (AMLN) Falls on Byetta Cancer Risk Memo 8:59 AM ET - StreetInsider Amylin Pharmaceuticals, Inc. falls on headlines Byetta may have veiled cancer risk.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.